171 related articles for article (PubMed ID: 14662730)
1. A truncated form of CKbeta8-1 is a potent agonist for human formyl peptide-receptor-like 1 receptor.
Elagoz A; Henderson D; Babu PS; Salter S; Grahames C; Bowers L; Roy MO; Laplante P; Grazzini E; Ahmad S; Lembo PM
Br J Pharmacol; 2004 Jan; 141(1):37-46. PubMed ID: 14662730
[TBL] [Abstract][Full Text] [Related]
2. Activation of the human FPRL-1 receptor promotes Ca2+ mobilization in U87 astrocytoma cells.
Kwan DH; Kam AY; Wong YH
Neurochem Res; 2008 Jan; 33(1):125-33. PubMed ID: 17703360
[TBL] [Abstract][Full Text] [Related]
3. Formyl peptide-receptor like-1 requires lipid raft and extracellular signal-regulated protein kinase to activate inhibitor-kappa B kinase in human U87 astrocytoma cells.
Kam AY; Liu AM; Wong YH
J Neurochem; 2007 Nov; 103(4):1553-66. PubMed ID: 17727628
[TBL] [Abstract][Full Text] [Related]
4. FPRL-1 induces modifications of migration-associated proteins in human neutrophils.
Boldt K; Rist W; Weiss SM; Weith A; Lenter MC
Proteomics; 2006 Sep; 6(17):4790-9. PubMed ID: 16892486
[TBL] [Abstract][Full Text] [Related]
5. Proinflammatory proteases liberate a discrete high-affinity functional FPRL1 (CCR12) ligand from CCL23.
Miao Z; Premack BA; Wei Z; Wang Y; Gerard C; Showell H; Howard M; Schall TJ; Berahovich R
J Immunol; 2007 Jun; 178(11):7395-404. PubMed ID: 17513790
[TBL] [Abstract][Full Text] [Related]
6. F2L, a peptide derived from heme-binding protein, inhibits formyl peptide receptor-mediated signaling.
Lee HY; Lee SY; Shin EH; Kim SD; Kim JM; Lee MS; Ryu SH; Bae YS
Biochem Biophys Res Commun; 2007 Aug; 359(4):985-90. PubMed ID: 17577578
[TBL] [Abstract][Full Text] [Related]
7. Selective binding of the truncated form of the chemokine CKbeta8 (25-99) to CC chemokine receptor 1(CCR1).
Berkhout TA; Gohil J; Gonzalez P; Nicols CL; Moores KE; Macphee CH; White JR; Groot PH
Biochem Pharmacol; 2000 Mar; 59(5):591-6. PubMed ID: 10660125
[TBL] [Abstract][Full Text] [Related]
8. Annexin 1 and its bioactive peptide inhibit neutrophil-endothelium interactions under flow: indication of distinct receptor involvement.
Hayhoe RP; Kamal AM; Solito E; Flower RJ; Cooper D; Perretti M
Blood; 2006 Mar; 107(5):2123-30. PubMed ID: 16278303
[TBL] [Abstract][Full Text] [Related]
9. The synthetic peptide Trp-Lys-Tyr-Met-Val-D-Met is a potent chemotactic agonist for mouse formyl peptide receptor.
He R; Tan L; Browning DD; Wang JM; Ye RD
J Immunol; 2000 Oct; 165(8):4598-605. PubMed ID: 11035102
[TBL] [Abstract][Full Text] [Related]
10. FPR2 signaling without β-arrestin recruitment alters the functional repertoire of neutrophils.
Gabl M; Holdfeldt A; Sundqvist M; Lomei J; Dahlgren C; Forsman H
Biochem Pharmacol; 2017 Dec; 145():114-122. PubMed ID: 28855087
[TBL] [Abstract][Full Text] [Related]
11. Peptide length and folding state govern the capacity of staphylococcal β-type phenol-soluble modulins to activate human formyl-peptide receptors 1 or 2.
Kretschmer D; Rautenberg M; Linke D; Peschel A
J Leukoc Biol; 2015 Apr; 97(4):689-97. PubMed ID: 25724390
[TBL] [Abstract][Full Text] [Related]
12. Identification and characterization of an endogenous chemotactic ligand specific for FPRL2.
Migeotte I; Riboldi E; Franssen JD; Grégoire F; Loison C; Wittamer V; Detheux M; Robberecht P; Costagliola S; Vassart G; Sozzani S; Parmentier M; Communi D
J Exp Med; 2005 Jan; 201(1):83-93. PubMed ID: 15623572
[TBL] [Abstract][Full Text] [Related]
13. Utilization of two seven-transmembrane, G protein-coupled receptors, formyl peptide receptor-like 1 and formyl peptide receptor, by the synthetic hexapeptide WKYMVm for human phagocyte activation.
Le Y; Gong W; Li B; Dunlop NM; Shen W; Su SB; Ye RD; Wang JM
J Immunol; 1999 Dec; 163(12):6777-84. PubMed ID: 10586077
[TBL] [Abstract][Full Text] [Related]
14. Stimulation of human formyl peptide receptors by calpain inhibitors: homology modeling of receptors and ligand docking simulation.
Fujita H; Kato T; Watanabe N; Takahashi T; Kitagawa S
Arch Biochem Biophys; 2011 Dec; 516(2):121-7. PubMed ID: 22005393
[TBL] [Abstract][Full Text] [Related]
15. N-Formylated humanin activates both formyl peptide receptor-like 1 and 2.
Harada M; Habata Y; Hosoya M; Nishi K; Fujii R; Kobayashi M; Hinuma S
Biochem Biophys Res Commun; 2004 Nov; 324(1):255-61. PubMed ID: 15465011
[TBL] [Abstract][Full Text] [Related]
16. Functional characterization of a human receptor for neuropeptide FF and related peptides.
Kotani M; Mollereau C; Detheux M; Le Poul E; Brézillon S; Vakili J; Mazarguil H; Vassart G; Zajac JM; Parmentier M
Br J Pharmacol; 2001 May; 133(1):138-44. PubMed ID: 11325803
[TBL] [Abstract][Full Text] [Related]
17. The synthetic peptide Trp-Lys-Tyr-Met-Val-Met-NH2 specifically activates neutrophils through FPRL1/lipoxin A4 receptors and is an agonist for the orphan monocyte-expressed chemoattractant receptor FPRL2.
Christophe T; Karlsson A; Dugave C; Rabiet MJ; Boulay F; Dahlgren C
J Biol Chem; 2001 Jun; 276(24):21585-93. PubMed ID: 11285256
[TBL] [Abstract][Full Text] [Related]
18. Antiflammin-2 activates the human formyl-peptide receptor like 1.
Kamal AM; Hayhoe RP; Paramasivam A; Cooper D; Flower RJ; Solito E; Perretti M
ScientificWorldJournal; 2006 Oct; 6():1375-84. PubMed ID: 17072491
[TBL] [Abstract][Full Text] [Related]
19. PKC-delta controls the fMLF-induced overproduction of superoxide by neutrophils.
Matron C; Chakravarti A; Allaeys I; Poubelle PE
Free Radic Biol Med; 2010 Jan; 48(2):207-15. PubMed ID: 19854263
[TBL] [Abstract][Full Text] [Related]
20. A novel nonpeptide ligand for formyl peptide receptor-like 1.
Nanamori M; Cheng X; Mei J; Sang H; Xuan Y; Zhou C; Wang MW; Ye RD
Mol Pharmacol; 2004 Nov; 66(5):1213-22. PubMed ID: 15308762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
